|
HS Code |
776020 |
As an accredited 5-Bromo-1H-Pyrrolo[2,3-C]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-1H-Pyrrolo[2,3-C]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
5-Bromo-1H-Pyrrolo[2,3-c]pyridine has been earning attention in chemical research circles, and for good reason. This heterocyclic compound, with the CAS number 91419-52-6, is more than just another piece on a synthetic chemist’s workbench. Anyone who has worked in pharmaceutical or agrochemical research knows how crucial building blocks like this can become, especially as drug discovery programs chase originality and better performance from molecules. Layering one brooding bromine atom onto the pyrrolopyridine core changes its reactivity profile, making it easier to attach further chemical groups in later steps. That’s a small tweak, but it opens doors to more creative chemistry.
The draw of 5-Bromo-1H-pyrrolo[2,3-c]pyridine comes from its very backbone: two fused rings of nitrogen and carbon, crowned with a strategically placed bromine atom. That fusion is anything but decorative. Chemists exploit the unique electron-rich space this creates, using the molecule as a springboard to more complicated compounds. Generating related structures takes less time and fewer steps compared to starting from scratch. I’ve seen synthetic teams cut weeks off their R&D timelines thanks to such core scaffolds. By anchoring bromine on this framework, researchers can direct cross-coupling reactions right where they want—at the fifth position. The result is a bold shortcut in making analogues of key bioactive compounds.
Most labs source 5-Bromo-1H-pyrrolo[2,3-c]pyridine in a solid, powdery form. Its melting point typically falls between 170 and 175°C, which makes storage and weighing straightforward. Keeping moisture away—never fun in humid climates—preserves its stability. Labs that care about purity will want a certificate of analysis, targeting at least 98% purity by HPLC or NMR. Experience shows even small impurities can sideline an entire series of syntheses, so suppliers who verify batch-to-batch quality make a difference. Light sensitivity also comes up; protecting the bottle with amber glass or foil saves a headache later.
It’s worth noting that serious suppliers include a safety data sheet, as inhaling fine powders or skin contact isn’t something to take lightly. Gloves, eye protection, good ventilation—these basics matter, especially in high-throughput screening environments where mistakes multiply fast. Following protocols helps the research move forward without interruptions.
In the early stages of drug discovery, chemists look for molecular frameworks that can react predictably and provide access to bigger, more complex structures. Pyrrolo[2,3-c]pyridines show up on the list because they help connect multiple drug-like molecules. By introducing bromine at the fifth position, the chemistry opens new routes for Suzuki and Stille couplings. These are staple reactions in medicinal chemistry, used both in academic and industrial drug design labs. My own time in a medicinal chemistry startup meant hours planning how to stretch limited budgets by leveraging compounds exactly like this—with 5-Bromo-1H-pyrrolo[2,3-c]pyridine turning up as the cost-effective solution over more complicated boron-based intermediates.
The agrochemical sector also takes interest. Plenty of active ingredients trace their roots to the pyridine or pyrrole core. Adding the fused framework and bromine offers sites for further functionalization, leading to molecules with increased pest resistance or improved plant absorption. The versatility makes this compound an attractive prospect for screening against a range of targets, cutting down the number of dead ends and maximizing the impact of each experiment.
Chemistry never goes exactly as planned. The difference-maker often comes down to access to robust intermediates that withstand diverse reaction conditions. Some synthesis plans falter because the starting materials demand too many protection and deprotection steps, running up costs and timelines. Having worked through these failures, I appreciate the subtle ways a well-chosen compound, such as 5-Bromo-1H-pyrrolo[2,3-c]pyridine, simplifies the roadmap.
Consider a cross-coupling project aiming for kinase inhibitor analogs. Traditional halogenated arenes easily unseat bromine in the presence of palladium catalysts; this intermediate stands out for its high selectivity during coupling, especially under mild conditions. Compounds based on simpler pyridines force chemists to wrestle with side reactions or excessive byproducts. If there’s a lesson here, it’s not just about trusting the literature but relying on firsthand trial and error. This compound has saved projects from stalling out. That hands-on reliability beats out theoretical advantages every time.
Anyone scanning chemical catalogs will notice just how many halogenated pyridines and pyrroles exist. The difference with 5-Bromo-1H-pyrrolo[2,3-c]pyridine isn’t only the fused ring system; it’s how it responds in the real-world lab. Many monohalogenated pyridines, such as 2-bromopyridine, bring their own quirks—some stubbornly resist cross-coupling, or produce regioisomer mixtures that complicate purification. By contrast, this particular pyrrolopyridine gives well-defined single products, saving time and boosting yield.
I’ve seen colleagues bemoan the unpredictability of other halogenated intermediates—sometimes the reaction just never gets past the halfway mark, leading to wasted resources. But the electronic properties in 5-Bromo-1H-pyrrolo[2,3-c]pyridine channel reactivity where it’s needed. The bromine acts as a perfect handle for fine-tuning the outcome, often producing final compounds with fewer troublesome side products than similar chlorinated or iodinated analogues.
Purity isn’t just a box to tick; in critical research, low-level contaminants can destroy confidence in results or force entire rounds of repeating experiments. Suppliers who cut corners become liability partners. I’ve seen project budgets balloon because a lower-cost supplier couldn’t deliver clean material batch after batch. The most reliable sources send thorough analytical data: spectra and chromatography peaks, leaving no doubts.
As for work in the lab, handling is straightforward with the right precautions. Clean spatulas, closed containers, and regular checks on shelf stability keep research on track. Material loss to decomposition is wasted money—so a refrigeration protocol isn’t overkill for long-term storage. These details sound small, but every experienced chemist knows they add up.
5-Bromo-1H-pyrrolo[2,3-c]pyridine has earned a place in the toolbox for synthetic organic and medicinal chemists. Its structure allows for a spectrum of transformations, from straightforward coupling reactions to more intricate multistep synthesis. As medicinal chemistry leans harder toward unexplored chemical space, compounds with fused heterocyclic frameworks step into the spotlight. Hit-to-lead campaigns benefit from transforms that unlock new scaffolds for bioactivity testing.
In addition to drug discovery, research into organic electronics and novel materials pulls from this family of molecules. The planar, aromatic rings enable π–π stacking, and the halogen atom can guide further functionalization toward advanced optoelectronic structures. The surge in demand for innovation in semiconductors, OLEDs, and molecular sensors keeps the appetite strong for these kinds of intermediates. While the use case might start with medicine, the journey often ends with applications in everything from smart coatings to cutting-edge display technologies.
Scaling synthesis from bench scale to multi-gram or pilot-plant batches isn’t always seamless. Classical lab setups don’t always translate as volume grows. Sometimes, solubility changes or heat management issues rear their heads once you move beyond small-scale reactions. From sitting in process chemistry meetings, I know these problems all too well. A reliable intermediate can make or break such a transition.
5-Bromo-1H-pyrrolo[2,3-c]pyridine shows some real-world resilience—its handling profile scales up without surprises in most common solvents. Solubility in polar aprotic solvents like DMF and DMSO means industrial equipment can dose it without awkward workarounds. Full transparency from suppliers—on physical properties and shelf-life—empowers teams to scale reactions safely. Some colleagues have switched suppliers mid-project due to this kind of communication breakdown, learning the hard way about unreported stability issues. Prioritizing open dialogue between researchers and suppliers keeps development timelines on track.
There’s a clear trend toward more complexity in modern molecule design. As research teams push into new chemical territory, the need for adaptable building blocks is only rising. 5-Bromo-1H-pyrrolo[2,3-c]pyridine will likely continue earning its keep as discovery workflows demand both reactive flexibility and reliability. So many biologically relevant scaffolds have their beginnings in fused-ring compounds, and adding halogens gives medicinal chemists just enough control without boxing them in.
Industry analysts have pointed out the continued growth of small-molecule pharma pipelines, especially for oncological and neurological diseases. In both cases, compounds with highly engineered ring systems show a track record for performance. Being able to reach new candidates by building off robust intermediates, like this one, shaves months or even years off development cycles. That can mean real relief for patients waiting on new therapies.
Every step forward in advanced chemical synthesis brings environmental questions. The bromination step in making 5-Bromo-1H-pyrrolo[2,3-c]pyridine involves hazardous reagents and generates waste. Over the past decade, the industry has made progress in developing milder, greener bromination protocols, focusing on recycling reagents and containing by-products. In my own work, minimizing solvent use and finding reusable catalysts have saved money and time, not just reduced environmental impact.
Real responsibility comes with constantly reviewing reaction routes and workup procedures, searching for ways to improve atom economy. Many research groups now publish method improvements in open journals, encouraging even commercial manufacturers to update their production lines. End-users, too, can play their part by choosing intermediates that enable shorter synthetic schemes. That’s a win both for operational budgets and for the world outside the laboratory walls.
The best advances in compound development come from sharing experience, not just reading technical bulletins. Partnerships between academic researchers, pharma startups, and material science companies drive the rapid improvement of core building blocks like 5-Bromo-1H-pyrrolo[2,3-c]pyridine. Some institutions have formed consortia for sharing analytical data, synthetic know-how, and even disposal techniques. From first-hand interaction at industry conferences, it’s clear these relationships matter—success stories travel fast, but so do warnings about purification pitfalls or supply chain hiccups.
Online platforms now make it easier to search peer-reviewed synthesis reviews and compare supplier performance across parameters such as price, purity, and delivery time. The field has moved on from relying solely on slick marketing materials. Direct feedback loops, whether through informal Slack groups or formalized online reviews, build trust in sources and processes. The effect ripples out: better chemistry, less waste, more discoveries, and higher standards across the industry.
For researchers, reliability and adaptability are worth their weight in gold. In today’s world, where supply chains can shift quickly and project schedules keep shortening, choosing intermediates like 5-Bromo-1H-pyrrolo[2,3-c]pyridine helps control the pace of progress. I’ve worked on teams where shifting to a more dependable building block saved months of dead time. Trusted intermediates form the backbone of innovation, anchoring larger, riskier bets later on.
Documentation, repeatable quality metrics, and safety-first support round out the value. Suppliers who meet these standards become long-term partners in discovery, not just vendors filling orders. Picking the right material is more than a spreadsheet exercise; it’s the difference between costly reruns and breakthrough ideas.
As chemical research grows ever more interdisciplinary, the importance of high-quality, versatile building blocks will only become more pronounced. In pharma, even a small edge in synthetic flexibility can spell the difference between a promising lead and a shelved idea. In agriculture, subtle changes in molecular structures can increase crop yields or sidestep stubborn resistance. In electronics, planar fused rings and precise halogenation pave the way for breakthroughs in semiconductors, displays, and sensors.
5-Bromo-1H-pyrrolo[2,3-c]pyridine stands as a clear example of a product that enables these incremental, deeply meaningful advances. Its fusion of structure, reactivity, and ease of handling positions it as a standout in a crowded landscape of intermediates. The lessons from years of laboratory experience tell the same story: the right starting point underpins every innovation that follows, laying the groundwork for whole generations of new solutions.